112 related articles for article (PubMed ID: 2847659)
1. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Namatame K; Sasaki E; Koh Y; Shimada K; Nakamura T; Hirose T; Ookubo M; Nakayoshi A
Gan To Kagaku Ryoho; 1992 May; 19(5):625-30. PubMed ID: 1580637
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy of UFT, etoposide and CDDP in advanced gastric cancer].
Hayakawa M; Morise K; Oka Y; Saito H
Gan No Rinsho; 1987 Jun; 33(7):793-8. PubMed ID: 3112439
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
Koda K; Nakazawa O; Morita K; Kure T; Terada S; Matsunaga T; Tsuji Y; Miyazaki E; Nakajima K; Morii K
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1893-900. PubMed ID: 2118336
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
[TBL] [Abstract][Full Text] [Related]
13. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced gastric cancer successfully treated by UFT and CDDP followed by surgical resection proving cancer cell disappearance in the stomach].
Muramoto M; Matsugaki K; Ogino K; Azuma M; Inukai A; Akao M; Nakai T; Manabe T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):581-4. PubMed ID: 9530366
[TBL] [Abstract][Full Text] [Related]
17. [Combined UFTM for 140 patients with advanced gastric cancer].
Jin ML
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
[TBL] [Abstract][Full Text] [Related]
18. [UFT/CDDP treatment in advanced gastric cancer--case report].
Suga S; Nagai H; Horiuchi Y; Ohkita T; Ibayashi J; Koyama Y
Gan No Rinsho; 1989 Jan; 35(1):87-92. PubMed ID: 2493527
[TBL] [Abstract][Full Text] [Related]
19. [A case of advanced gastric cancer responding to an FAP (5-FU, ADM, platinum compounds) combined chemotherapy].
Miyahara E; Takiyama W; Sakamoto N; Azuma T; Ohashi R; Kirihara Y; Doihara H; Yokoyama N; Tanada M; Soga H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):643-6. PubMed ID: 8470923
[TBL] [Abstract][Full Text] [Related]
20. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
Içli F; Celik I; Aykan F; Uner A; Demirkazik A; Ozet A; Ozgüroğlu M; Taş F; Akbulut H; Firat D
Cancer; 1998 Dec; 83(12):2475-80. PubMed ID: 9874451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
